Article
Targeting BET Proteins downregulates miR-33a to promote synergy with PIM inhibitors in…
bioRxiv · 2022 · Christopher T. Letson
Key facts
| Title | Targeting BET Proteins downregulates miR-33a to promote synergy with PIM inhibitors in CMML |
|---|---|
| First author | Christopher T. Letson |
| Journal | bioRxiv |
| Published | Nov 2, 2022 |
| DOI | 10.1101/2022.11.01.514753 |
| Devices mentioned | K202641, K220060, K231013 |
| Product codes mentioned | MVU, NGT, NSU, PFF, PFT, PFX, QBD |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1